Skip to main content
Equibles
RMD logo

RMD

Resmed Inc
$219.75 +1.35 (+0.62%) At close · Jul 7
Market Cap
$31.88B
Shares
145,056,384

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$219.75 Open$219.34 Day$216.52–219.98 52W$180.27–292.44 Avg vol 30d1.4M Short int12.9M · 8.9% float · 9.0d Short vol76% Last earningsAug 6, 2026 DataJan 2020–Jul 2026 Filing10-Q · May 1
Equibles Rating blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 16.9 · calm Equity put/call 0.86
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −8%
below
Price vs 50-day avg +9%
above
RSI (14) 69
neutral
MACD trend Positive
52-week position 35%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +12%
trailing
6-month return −15%
trailing
YTD return −9%
this year
Relative strength −22%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $202 › 200d $239 — 200d above 50d
Institutional flow Accumulating
27 of 942 funds reported for Jun 30 · net +13.3K sh shares · +1 new
Insider flow Distributing
Net -$2.0M over 90 days · 100% sells
Short interest Rising
8.90% of float · ▲ +8.7% MoM · 9.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
942 holders — near 3-yr high, broad support
Squeeze score 79
high risk · 0–100
Fundamentals
Excellent
Revenue growth +13%
Y/Y
Gross margin 103%
expanding
EPS growth +37%
Y/Y
Free cash flow $1.7B
Valuation P/E 21.2
below peers
Balance sheet $551.1M
net cash
Quant / Vol
risk profile
Moderate
Volatility 26%
annualized · 1-yr
Max drawdown −37%
past year
ATR 2.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next
Next earnings call
Aug 6, 2026 Scheduled · in 4 wks
FQ1-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 1, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −8% Bearish
      Price vs 50-day avg
      +9% Bullish
      RSI (14)
      69 Neutral
      MACD trend
      Positive Bullish
      52-week position
      35% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $202 › 200d $239 — 200d above 50d
      Institutional flow Accumulating
      27 of 942 funds reported for Jun 30 · net +13.3K sh shares · +1 new
      Insider flow Distributing
      Net -$2.0M over 90 days · 100% sells
      Short interest Rising
      8.90% of float · ▲ +8.7% MoM · 9.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      942 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $180 Now $220 · 35% 52-wk high $292
      vs 200-day avg -8% vs 50-day avg +9%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      MatrixCare business non-GAAP operating profit non-GAAP 55M full fiscal year 2026 —
      MatrixCare business revenue 220M full fiscal year 2026 —
      Operating cash flow $340M Q2 FY2026 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RMD
      Resmed Inc
      this stock
      		$31.88B -8.6% +13.4% 21.2 8.9%
      ISRG
      Intuitive Surgical Inc
      		 $147.01B -24.6% +20.5% 50.4 2.2%
      MDLN
      Medline Inc.
      		 $52.94B -4.0% +11.5% — 2.1%
      BDX
      Becton Dickinson & Co
      		 $41.49B +3.8% +8.2% 57.2 2.6%
      ALC
      Alcon Inc
      		 $32.61B -15.2% — — 1.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      938
      % held
      62.4%
      Reported
      27 of 942
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      742
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      12.9M
      Days to cover
      9.0d
      Change
      +1.0M sh
      View
      Short Volume
      Short vol %
      76%
      As of
      Jul 8, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      245
      Value
      $45.7K
      As of
      Jun 4, 2026
      View
      Off-Exchange
      Off-exchange %
      45.8%
      Week of
      Jun 15, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$2.0M
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Congressional Trades Sell
      Member
      Kelly Louise Morrison
      Amount
      $1.0K–$15.0K
      Traded
      Jun 4, 2025
      View
      Financials
      Financials
      Revenue (FY)
      $5.1B
      Net income (FY)
      $1.4B
      EPS diluted
      $9.51
      View
      Buybacks
      Authorized
      shares 20.0M
      Remaining
      shares 10.8M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jul 7, 2026
      This year
      6
      View
      Proposed Sales
      Value
      $1.1M
      Shares
      5.0K
      Filed
      Jul 7, 2026
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Aug 6, 2026
      Last call
      Jul 7, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      RMD +9.5% +12.1% -14.6% +12.8% -8.6%
      SPY +0.9% +1.4% +7.6% +0.1% +9.7%
      vs SPY +8.6% +10.7% -22.1% +12.6% -18.2%

      Capital returns

      Latest dividend
      $0.60 / share · ex May 14, 2026
      Raised 13.2%
      Paid (TTM)
      $2.40 / share · 4 payouts
      Dividend yield (TTM, derived)
      1.09%
      Buyback program · as of Jun 30, 2025
      Authorized
      shares 20.00M
      Spent (derived)
      shares 9.20M
      Remaining
      shares 10.80M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 943819 CUSIP 761152107 13F (30d) 48 filings 26 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)